KW-6500
6500-005
Phase 3 small_molecule completed
Quick answer
KW-6500 for Parkinson's Disease is a Phase 3 program (small_molecule) at KYOWA KIRIN AUSTRALIA PTY LTD with 1 ClinicalTrials.gov record(s).
Program details
- Company
- KYOWA KIRIN AUSTRALIA PTY LTD
- Indication
- Parkinson's Disease
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- completed